Live Analyst Rating Changes 1511 upgrades, downgrades & price-target moves · freshest Wall Street data, updated daily View live feed →
Analyst Tracker/Celine Pannuti CFA
JPM
Celine Pannuti CFA
J.P. Morgan
Wall Street Analyst
★★★★☆
#686
on 13Foresight · ranked by our own returns
75%
Success Rate
+13.5%
Average Return
6 of 8 calls profitable · -11.6% vs benchmark
🔒 5-year track record is Pro. Showing 1-year — upgrade.
📈 Across the calls we could measure, roughly 75% of Celine Pannuti CFA's ratings turned a profit when each position was held for 1 year — averaging +13.5% per rating. These figures are computed by 13Foresight from historical prices, not supplied by the analyst.

Rating Distribution

83 Buy 90 Hold 22 Sell
Celine's Stock Coverage 37 ratings · 2026-06-19
Company Date Position Consensus ⓘ Price Target ⓘ 1-Yr Return
FR:OR
L'Oreal
 Jun 18, 2026 HOLD Buy
+0.2% avg upside
25 analysts
$365.00
5.00% Downside
 ·
GB:ULVR
Unilever
 Jun 09, 2026 BUY Buy
+264.6% avg upside
25 analysts
$5700.00
29.49% Upside
 ·
CH:GIVN
Givaudan SA
 Jun 09, 2026 BUY Buy
+11.3% avg upside
15 analysts
$3600.00
12.33% Upside
 ·
CH:NESN
Nestlé SA
 Jun 03, 2026 HOLD Buy
+19.4% avg upside
27 analysts
$90.00
14.27% Upside
 ·
FR:BN
DANONE SA
 Jun 02, 2026 BUY Buy
+12.8% avg upside
22 analysts
$90.00
37.45% Upside
 ·
DE:BEI
Beiersdorf
 May 29, 2026 HOLD Hold
+32.2% avg upside
23 analysts
$90.00
23.75% Upside
 ·
DE:HEN3
Henkel AG & Co. KGaA
 May 13, 2026 SELL Hold
+10.3% avg upside
20 analysts
 — ·
NL:HEIA
Heineken NV
 May 13, 2026 HOLD Strong Buy
+28.3% avg upside
18 analysts
$70.00
0.44% Downside
 ·
GB:DGE
Diageo
 May 12, 2026 HOLD Buy
+438.3% avg upside
26 analysts
$1800.00
17.62% Upside
 ·
BUD
Anheuser-Busch Inbev Sa
 May 07, 2026 BUY Strong Buy
+3.7% avg upside
27 analysts
$93.83
16.09% Upside
 +2.0%
GB:0RJI
Anheuser Busch InBev SA/NV
 May 05, 2026 BUY Strong Buy
+8.8% avg upside
26 analysts
$73.00
2.42% Upside
 ·
SE:ESSITY.B
Essity AB
 Apr 20, 2026 SELL Hold
+4.0% avg upside
10 analysts
$215.00
19.71% Downside
 ·
SE:ESSITY.A
Essity Aktiebolag
 Mar 25, 2026 HOLD Buy
+8.8% avg upside
5 analysts
$245.00
8.46% Downside
 ·
FR:RI
Pernod Ricard
 Mar 18, 2026 HOLD Buy
+57.1% avg upside
20 analysts
$90.00
41.74% Upside
 ·
ES:PUIG
Puig Brands, S.A.
 Mar 17, 2026 HOLD Strong Buy
+17.7% avg upside
5 analysts
$16.00
0.04% Downside
 ·
GB:RKT
Reckitt
 Mar 09, 2026 HOLD Strong Buy
+1107.4% avg upside
21 analysts
$5800.00
25.01% Upside
 ·
NL:MICC
Magnum Ice Cream Co. N.V.
 Feb 25, 2026 HOLD Buy
-3.4% avg upside
7 analysts
$13.00
11.14% Downside
 ·
DE:SY1
Symrise
 Dec 15, 2025 BUY Strong Buy
+23.8% avg upside
16 analysts
$105.00
22.76% Upside
 ·
GB:HLN
Haleon PLC
 Nov 26, 2025 SELL Strong Buy
+32.8% avg upside
20 analysts
$335.00
0.74% Upside
 ·
PM
Philip Morris
 Nov 26, 2025 BUY Strong Buy
-4.4% avg upside
22 analysts
$185.00
2.92% Upside
 +19.8%
GB:BATS
British American Tobacco
 Nov 26, 2025 HOLD Strong Buy
+573.0% avg upside
17 analysts
$4150.00
6.13% Downside
 ·
GB:0AI4
Carlsberg AS
 Nov 26, 2025 BUY Buy
+20.7% avg upside
20 analysts
$975.00
15.99% Upside
 ·
IT:CPR
Davide Campari-Milano SpA
 Oct 30, 2025 HOLD Buy
+43.5% avg upside
18 analysts
$6.00
10.04% Upside
 ·
FR:RCO
Remy Cointreau
 Jul 08, 2025 SELL Hold
+135.1% avg upside
16 analysts
$40.00
11.82% Downside
 ·
DE:HEN
Henkel AG & Co. KGaA
 May 09, 2024 HOLD Hold
+16.8% avg upside
13 analysts
$79.00
19.30% Upside
 ·
GB:CCH
Coca Cola HBC
 Apr 03, 2024 HOLD Strong Buy
-19.4% avg upside
15 analysts
$2350.00
48.83% Downside
 ·
CCEP
Coca-Cola Europacific Partners
 Nov 29, 2023 BUY Strong Buy
-9.1% avg upside
25 analysts
$81.29
16.74% Downside
 +33.6%
GB:0R6Z
Royal UNIBREW A/S
 Nov 29, 2023 HOLD Hold
+16.8% avg upside
13 analysts
$500.00
19.11% Upside
 ·
GB:FEVR
Fevertree Drinks
 Nov 29, 2023 HOLD Hold
+47.7% avg upside
17 analysts
$1150.00
38.57% Upside
 ·
DEO
Diageo
 Nov 28, 2023 HOLD Buy
+543.1% avg upside
18 analysts
 — -13.1%
HENKY
Henkel AG
 Nov 21, 2023 HOLD Buy
+312.6% avg upside
8 analysts
$81.29
327.37% Upside
 +11.9%
GB:IMB
Imperial Brands
 Nov 20, 2023 BUY Strong Buy
+1493.7% avg upside
17 analysts
$2250.00
18.37% Downside
 ·
DANOY
Danone SA
 Apr 26, 2023 BUY Buy
+92.6% avg upside
10 analysts
$81.29
439.19% Upside
 -2.9%
GB:KYGA
Kerry Group plc
 Dec 01, 2022 BUY Strong Buy
+43.4% avg upside
7 analysts
$118.00
58.09% Upside
 ·
GB:0QVQ
Ontex Group N.V.
 Feb 25, 2022 HOLD Hold
+343.8% avg upside
5 analysts
$6.00
147.93% Upside
 ·
HEINY
Heineken
 Jul 01, 2020 HOLD Hold
+148.5% avg upside
9 analysts
$92.90
130.42% Upside
 +33.3%
NSRGY
Nestle SA Reg
 Dec 10, 2018 BUY Buy
+22.1% avg upside
11 analysts
 — +23.5%
🔒 32 more ratings — with price targets, crowd consensus and our measured returns.
Sign in free to unlock See Pro plans
Free account unlocks every analyst's full coverage table.
Celine Pannuti CFA — Frequently Asked Questions
How accurate are Celine Pannuti CFA's stock ratings?
Based on the calls 13Foresight could measure, about 75% of Celine's ratings were profitable over a one-year hold, with an average return of +13.5% per rating, or -11.6% versus the S&P 500. We score every analyst the same way, from historical prices.
How is Celine ranked on 13Foresight?
Celine Pannuti CFA is currently ranked #686 with a 4-star rating. Our rank blends hit rate, average return versus the market, and how many calls we have to judge — so a long, consistent record outweighs a few lucky picks. It is our own calculation, updated daily.
Which stocks does Celine cover?
Celine most recently has ratings on FR:OR, GB:ULVR, CH:GIVN, CH:NESN, FR:BN, DE:BEI, DE:HEN3, NL:HEIA, GB:DGE, BUD, GB:0RJI, SE:ESSITY.B and 25 more. See the full coverage table above for positions, price targets and our measured returns.
Where can I see other analyst ratings?
Browse the full analyst leaderboard to compare Wall Street analysts ranked by their measured performance, success rate and average return.

Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.